• contact@inkerman-lab.com
  • +230 464 4839
  • Inkerman Medical Laboratory (IML)

About Us

Home > Our Specialities > Microbiology
  • Contact
  • Inkerman Medical Laboratory
  • +230 464 4839
  • +230 464 4839
  • contact@inkerman-lab.com

Cancer Screening

The prostate

The prostate is below the bladder (the hollow organ where urine is stored) and in front of the rectum (the last part of the intestines). Just behind the prostate are glands called seminal vesicles, which make most of the fluid for semen. The urethra, which is the tube that carries urine and semen out of the body through the penis, goes through the center of the prostate.

Prostate Cancer Screening

(American Cancer Society)

Prostate is the commonest cancer in males and risk increases with age.

The discussion about screening should take place at:

  • Age 50 for men who are at average risk of prostate cancer and are expected to live at least 10 more years
  • Age 45 for men at high risk of developing prostate cancer. This includes African American men and men who have a first-degree relative (father or brother) diagnosed with prostate cancer at an early age (younger than age 65).
  • Age 40 for men at even higher risk (those with more than one first-degree relative who had prostate cancer at an early age)

Screening steps includes:

PSA ( Prostate Specific Antigen) Blood test

PSA can be done on a routine blood sample. The test must be carried out in the absence of urinary infections and instrumentation to bladder.

Digital Rectal
Examination

This is a clinical examination where a doctor examines the prostate by putting a gloved finger in the rectum to assess the prostate gland.

Prostate ultrasound examination ( Echography)

The prostate ultrasound allows visualisation of the organs to assesses the prostate and bladder, to look for abnormalities.

Following the screening test, the doctor will explain the results and decide if further investigations are warranted or not.